Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Vertigo Market: Industry Analysis & Outlook 2017-2021: Major Players are Auris Medical, Sensorion, Otonomy and Sound Pharmaceuticals - Research and Markets

Research and Markets
Posted on: 19 Dec 17

The "Global Vertigo Market: Industry Analysis & Outlook (2017-2021)" report has been added to Research and Markets' offering.

Global Vertigo Market: Industry Analysis & Outlook (2017-2021) analyzes the development of this market, with focus on Europe and US regions. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report.

Peripheral vertigo can be further segmented into five major categories: Benign paroxysmal positional vertigo (BPPV), Acute Unilateral Vestibulopathy, Meniere's disease and Vestibular Schwannoma. Amongst all the stated indication, Meniere's disease represents the largest growth opportunity for the market players with its continuously rising incidence.

Growth of global vertigo market is expected to be driven by factors such as rising incidence and prevalence of peripheral etiologies of vertigo, increasing geriatric population, growing healthcare expenditure and improving disposable income. Further, the market growth could be hindered by side effects of currently prescribed medication, the high cost of treatment and tedious drug approval process. The key trends for the market include extensive research & development and different approaches being adopted by drug manufacturers in order to target vertigo.

A key drug Otividex, which is currently in third phase of clinical trials and is being developed by Otonomy Inc., is discussed in the report. The drug is easier to use and provides a higher and sustained concentration of dexamethasone relative to existing injections. Further, it is anticipated to provide a well-accepted treatment option for Meniere's Disease, if successfully developed.

The four major players involved in the development of breakthrough drug therapy for vertigo: Auris Medical Holding AG., Sensorion SA, Otonomy, Inc. and Sound Pharmaceuticals, Inc. are being profiled along with their key financials and strategies for growth.

Key Topics Covered:

1. Introduction

2. Global Vertigo Market

3. Regional Market

4. Market Dynamics

5. Competitive Landscape

6. Company Profiles

  • Auris Medical Holding AG
  • Otonomy, Inc.
  • Sensorion SA
  • Sound Pharmaceuticals, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/ddtldk/global_vertigo?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20171219006083/en/

Business Wire
www.businesswire.com

Last updated on: 19/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.